MRD Monitoring in Acute Lymphoblastic Leukemia
0 vistas
• 06/15/23
0
0
Empotrar
administrator
Suscriptores
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios